HealthEquity SG&A Expenses 2014-2025 | HQY
HealthEquity annual/quarterly sg&a expenses history and growth rate from 2014 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- HealthEquity sg&a expenses for the quarter ending April 30, 2025 were $0.052B, a 16.54% decline year-over-year.
- HealthEquity sg&a expenses for the twelve months ending April 30, 2025 were $0.213B, a 6.83% increase year-over-year.
- HealthEquity annual sg&a expenses for 2025 were $0.223B, a 21.9% increase from 2024.
- HealthEquity annual sg&a expenses for 2024 were $0.183B, a 9.99% increase from 2023.
- HealthEquity annual sg&a expenses for 2023 were $0.166B, a 15.47% increase from 2022.
| HealthEquity Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025 | $223 |
| 2024 | $183 |
| 2023 | $166 |
| 2022 | $144 |
| 2021 | $134 |
| 2020 | $105 |
| 2019 | $63 |
| 2018 | $48 |
| 2017 | $38 |
| 2016 | $27 |
| 2015 | $19 |
| 2014 | $12 |
| 2013 | $11 |
| HealthEquity Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025-04-30 | $52 |
| 2025-01-31 | $53 |
| 2024-10-31 | $54 |
| 2024-07-31 | $54 |
| 2024-04-30 | $62 |
| 2024-01-31 | $44 |
| 2023-10-31 | $47 |
| 2023-07-31 | $47 |
| 2023-04-30 | $45 |
| 2023-01-31 | $42 |
| 2022-10-31 | $42 |
| 2022-07-31 | $42 |
| 2022-04-30 | $40 |
| 2022-01-31 | $38 |
| 2021-10-31 | $33 |
| 2021-07-31 | $38 |
| 2021-04-30 | $35 |
| 2021-01-31 | $36 |
| 2020-10-31 | $35 |
| 2020-07-31 | $33 |
| 2020-04-30 | $30 |
| 2020-01-31 | $37 |
| 2019-10-31 | $32 |
| 2019-07-31 | $18 |
| 2019-04-30 | $18 |
| 2019-01-31 | $16 |
| 2018-10-31 | $17 |
| 2018-07-31 | $15 |
| 2018-04-30 | $14 |
| 2018-01-31 | $14 |
| 2017-10-31 | $12 |
| 2017-07-31 | $11 |
| 2017-04-30 | $10 |
| 2017-01-31 | $10 |
| 2016-10-31 | $10 |
| 2016-07-31 | $10 |
| 2016-04-30 | $9 |
| 2016-01-31 | $8 |
| 2015-10-31 | $7 |
| 2015-07-31 | $7 |
| 2015-04-30 | $6 |
| 2015-01-31 | $7 |
| 2014-10-31 | $5 |
| 2014-07-31 | $4 |
| 2014-04-30 | $3 |
| 2014-01-31 | |
| 2013-10-31 | $3 |
| 2013-07-31 | $3 |
| 2013-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.752B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.515B | 26.35 |
| CVS Health (CVS) | United States | $84.516B | 10.51 |
| Elevance Health (ELV) | United States | $84.143B | 10.86 |
| Cencora (COR) | United States | $56.815B | 19.77 |
| Natera (NTRA) | United States | $23.263B | 0.00 |
| DiDi Global (DIDIY) | China | $22.732B | 24.15 |
| Labcorp Holdings (LH) | United States | $21.849B | 17.72 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.354B | 0.00 |
| CochLear (CHEOY) | Australia | $12.742B | 0.00 |
| Solventum (SOLV) | United States | $12.673B | 13.42 |
| ICON (ICLR) | Ireland | $11.895B | 11.06 |
| Revvity (RVTY) | United States | $11.192B | 19.26 |
| Viatris (VTRS) | United States | $10.387B | 3.57 |
| Avantor (AVTR) | United States | $9.152B | 13.30 |
| Medpace Holdings (MEDP) | United States | $8.871B | 23.56 |
| Sonic Healthcare (SKHHY) | Australia | $8.201B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.239B | 14.19 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.245B | 25.00 |
| BrightSpring Health Services (BTSG) | United States | $4.003B | 36.73 |
| Sotera Health (SHC) | United States | $3.148B | 17.89 |
| Alignment Healthcare (ALHC) | United States | $2.764B | 0.00 |
| Concentras Parent (CON) | United States | $2.689B | 15.54 |
| Surgery Partners (SGRY) | United States | $2.589B | 33.67 |
| Organon (OGN) | United States | $2.548B | 2.71 |
| GeneDx Holdings (WGS) | United States | $2.274B | 87.59 |
| PACS (PACS) | United States | $1.943B | 0.00 |
| Ardent Health (ARDT) | United States | $1.851B | 7.89 |
| Premier (PINC) | United States | $1.802B | 13.68 |
| Progyny (PGNY) | United States | $1.782B | 39.23 |
| GoodRx Holdings (GDRX) | United States | $1.675B | 33.50 |
| Teladoc Health (TDOC) | United States | $1.384B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.149B | 8.74 |
| Establishment Labs Holdings (ESTA) | $1.058B | 0.00 | |
| CareDx (CDNA) | United States | $1.055B | 16.48 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.890B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.811B | 7.59 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| LifeMD (LFMD) | United States | $0.650B | 0.00 |
| Nutex Health (NUTX) | United States | $0.649B | 9.83 |
| Embecta (EMBC) | United States | $0.574B | 3.87 |
| InnovAge Holding (INNV) | United States | $0.536B | 0.00 |
| Enhabit (EHAB) | United States | $0.470B | 38.67 |
| Auna S.A (AUNA) | Luxembourg | $0.463B | 10.42 |
| Sonida Senior Living (SNDA) | United States | $0.457B | 0.00 |
| SBC Medicals (SBC) | United States | $0.450B | 0.00 |
| Omada Health (OMDA) | $0.382B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.281B | 0.00 |
| Beauty Health (SKIN) | United States | $0.243B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.220B | 0.00 |
| Oncology Institute (TOI) | United States | $0.204B | 0.00 |
| DocGo (DCGO) | United States | $0.172B | 28.17 |
| So-Young (SY) | China | $0.168B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.130B | 0.00 |
| OncoCyte (IMDX) | United States | $0.105B | 0.00 |
| KindlyMD (NAKA) | United States | $0.098B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| Biodesix (BDSX) | United States | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |